Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neumora Therapeutics
Biotech
Neumora schizophrenia drug on FDA hold over rabbit convulsions
The FDA placed a phase 1 trial of Neumora’s NMRA-266 on hold after preclinical data revealed rabbits dosed with the drug had experienced convulsions.
James Waldron
Apr 15, 2024 9:00am
Pfizer's migraine market chief joins Apnimed—Chutes & Ladders
Jan 26, 2024 9:30am
Jay Bradner returns to lead R&D at Amgen—Chutes & Ladders
Dec 15, 2023 9:30am
CEPI's founding CEO to lead Wellcome—Chutes & Ladders
Oct 13, 2023 9:30am
RayzeBio scores $311M oversized IPO, Neumora hits $250M target
Sep 15, 2023 8:48am
Neumora, RayzeBio seeking more than $200M each in IPOs
Sep 11, 2023 12:13pm
